MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 338 filers reported holding MEDIVATION INC in Q4 2014. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $10,727,000 | -16.7% | 177,901 | -36.6% | 0.05% | -17.9% |
| Q1 2016 | $12,884,000 | -17.8% | 280,420 | -13.6% | 0.06% | -16.4% |
| Q4 2015 | $15,683,000 | +192.6% | 324,441 | +157.3% | 0.07% | +179.2% |
| Q3 2015 | $5,360,000 | -27.1% | 126,116 | +96.0% | 0.02% | -20.0% |
| Q2 2015 | $7,350,000 | -9.2% | 64,358 | +2.6% | 0.03% | -9.1% |
| Q1 2015 | $8,096,000 | +275.9% | 62,725 | +190.1% | 0.03% | +266.7% |
| Q4 2014 | $2,154,000 | -1.5% | 21,625 | -2.3% | 0.01% | 0.0% |
| Q3 2014 | $2,187,000 | +31.7% | 22,125 | +2.7% | 0.01% | +28.6% |
| Q2 2014 | $1,661,000 | +19.8% | 21,550 | 0.0% | 0.01% | +16.7% |
| Q1 2014 | $1,387,000 | +1344.8% | 21,550 | +1336.7% | 0.01% | – |
| Q4 2013 | $96,000 | +6.7% | 1,500 | 0.0% | 0.00% | – |
| Q3 2013 | $90,000 | -92.2% | 1,500 | -93.6% | 0.00% | -100.0% |
| Q2 2013 | $1,158,000 | – | 23,530 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,484,101 | $148,897,000 | 79.45% |
| BB BIOTECH AG | 1,449,706 | $86,895,000 | 4.73% |
| SECTORAL ASSET MANAGEMENT INC | 1,013,529 | $60,751,000 | 2.92% |
| Orbimed Advisors | 2,284,500 | $136,933,000 | 2.44% |
| Archipel Asset Management AB | 191,016 | $11,449,000 | 2.35% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 147,060 | $8,815,000 | 1.43% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 450,000 | $26,973,000 | 1.32% |
| QVT Financial LP | 305,128 | $18,289,000 | 1.24% |
| Bain Capital Public Equity Management, LLC | 825,687 | $49,492,000 | 1.24% |
| Tradeworx Inc. | 44,484 | $2,666,000 | 1.22% |